Divis Laboratories Ltd reported 87.49 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Aurobindo Pharma 21.78 0 Mar/2025
Divis Laboratories Ltd 87.49 13.33 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 20.69 1.92 Jun/2025
Lupin 30.91 10.12 Jun/2025
Moderna 27.22 14.51 Jun/2023
Organon & Co 2.58 1.6 Jun/2025
Revvity 40.39 5.61 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 22.25 216.55 Jun/2025